ConvaTec Group (FRA:2CV) EBIT per Share : €0.12 (TTM As of Jun. 2024)

View and export this data going back to 2016. Start your Free Trial

What is ConvaTec Group EBIT per Share?

ConvaTec Group's EBIT per Share for the six months ended in Jun. 2024 was €0.06. Its EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2024 was €0.12.

During the past 12 months, the average EBIT per Share Growth Rate of ConvaTec Group was 9.80% per year. During the past 3 years, the average EBIT per Share Growth Rate was 9.40% per year. During the past 5 years, the average EBIT per Share Growth Rate was 6.90% per year. During the past 10 years, the average EBIT per Share Growth Rate was -0.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for ConvaTec Group's EBIT per Share or its related term are showing as below:

FRA:2CV' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -25.6 Med: 3.65 Max: 34
Current: 9.4

During the past 11 years, the highest 3-Year average EBIT per Share Growth Rate of ConvaTec Group was 34.00% per year. The lowest was -25.60% per year. And the median was 3.65% per year.

FRA:2CV's 3-Year EBIT Growth Rate is ranked better than
54.34% of 714 companies
in the Medical Devices & Instruments industry
Industry Median: 6.95 vs FRA:2CV: 9.40

ConvaTec Group's EBIT for the six months ended in Jun. 2024 was €131 Mil.

ConvaTec Group EBIT per Share Historical Data

The historical data trend for ConvaTec Group's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ConvaTec Group EBIT per Share Chart

ConvaTec Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

0.04

0.09

0.08

0.06

0.11

ConvaTec Group Semi-Annual Data
	Dec13	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
EBIT per Share	Get a 7-Day Free Trial															0.04	0.03	0.05	0.06	0.06

ConvaTec Group EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

ConvaTec Group's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	220.722	/	2052.589
=	0.11

ConvaTec Group's EBIT per Share for the quarter that ended in Jun. 2024 is calculated as

	EBIT per Share		(Q: Jun. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	130.896	/	2055.953
=	0.06

EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.12

ConvaTec Group (FRA:2CV) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

ConvaTec Group EBIT per Share Related Terms

Thank you for viewing the detailed overview of ConvaTec Group's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

ConvaTec Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ConvaTec Group PLC (FRA:2CV) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

CNVVF:USA CNVVY:USA CTECl:UK CTEC:UK

Address

20 Eastbourne Terrace, 7th Floor, Paddington, London, GBR, W2 6LG

Website

https://www.convatecgroup.com

Originally spun out of Bristol-Myers Squibb, Convatec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute-care hospital and chronic-care home settings. Advanced wound care and ostomy supplies are the largest divisions, accounting for 33% and 29% of total revenue, respectively. Continence care has become a slightly smaller business (21% of revenue) following the decision to exit the acute care market, and infusion sets contribute 17% of consolidated revenue.

ConvaTec Group Headlines

No Headlines